You have 9 free searches left this month | for more free features.

veliparib

Showing 1 - 25 of 97

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound,

No longer available
  • Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
  • +3 more
  • Veliparib
  • (no location specified)
May 20, 2022

Metastatic Triple Negative Breast Cancer Trial in Birmingham (Combination of Veliparib + Lapatinib)

Active, not recruiting
  • Metastatic Triple Negative Breast Cancer
  • Combination of Veliparib + Lapatinib
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 25, 2022

Malignant Solid Tumor Trial in United States (drug, other, procedure)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Baltimore, Maryland
  • +5 more
Nov 8, 2022

Cancer - Ovarian Trial (Veliparib, capsule, Veliparib, tablet, Carboplatin)

Withdrawn
  • Cancer - Ovarian
  • Veliparib, capsule
  • +3 more
  • (no location specified)
Dec 6, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Chicago, Illinois
  • +11 more
Jun 28, 2022

Tumors Trial in Bethesda, Boston, Houston (Veliparib + VX-970 + Cisplatin)

Completed
  • Neoplasms
  • Veliparib + VX-970 + Cisplatin
  • Bethesda, Maryland
  • +2 more
Jan 14, 2022

Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

Active, not recruiting
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 28, 2023

Advanced Solid Tumors Trial (veliparib (ABT-888), carboplatin, gemcitabine)

Completed
  • Advanced Solid Tumors
  • veliparib (ABT-888)
  • +2 more
  • (no location specified)
Jul 29, 2021

Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation, Triple-Negative Breast Cancer Trial in Seattle (Veliparib,

No longer available
  • Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
  • Triple-Negative Breast Cancer
  • Veliparib
  • +2 more
  • Seattle, Washington
    Seattle Cancer Care Allliance
Jul 14, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Phoenix, Arizona
  • +14 more
Sep 1, 2022

Testicular Cancer Trial in Bratislava (Veliparib, Gemcitabine, Carboplatin)

Completed
  • Testicular Cancer
  • Veliparib
  • +2 more
  • Bratislava, Slovakia
    National Cancer Institute
Mar 2, 2021

Pancytopenia Related to PARP Inhibitors (PancytoRIB)

Completed
  • Cancer
  • PARP inhibitor
  • Caen, Basse Normandie, France
    Alexandre Joachim
Sep 16, 2021

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Small Cell Lung Cancer SCLC Trial in München Gauting (veliparib, Topotecan)

Recruiting
  • Small Cell Lung Cancer SCLC
  • München Gauting, Germany
    Klinik München Gauting
Jan 26, 2021

Gastric Cancer Trial in Korea, Republic of, United States (Veliparib)

Completed
  • Gastric Cancer
  • Veliparib
  • Scottsdale, Arizona
  • +7 more
Jul 29, 2021

Pulmonary Toxicities Related to PARP Inhibitors (PulmonaRIB)

Recruiting
  • Cancer
  • olaparib, rucaparib, niraparib, talazoparib, veliparib, pamiparib
  • Caen, Basse Normandie, France
    Alexandre Joachim
May 27, 2021

Advanced Solid Tumor, Aggressive Non-Hodgkin Lymphoma, Recurrent Solid Tumor Trial in Chicago (other, biological, drug)

Unknown status
  • Advanced Solid Neoplasm
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
    Northwestern University
Oct 27, 2020

Pancreatic Cancer Trial in Los Angeles (Veliparib, Gemcitabine, Intensity modulated radiation therapy)

Completed
  • Pancreatic Cancer
  • Veliparib
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jul 13, 2020

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
  • Advanced Malignant Solid Neoplasm
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

NSCLC Stage III Trial in United States (Paclitaxel, Placebo for Veliparib, Carboplatin)

Terminated
  • Non-small Cell Lung Cancer Stage III
  • La Jolla, California
  • +11 more
Jul 8, 2020

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Castration-Resistant Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in United States

Completed
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +3 more
  • Duarte, California
  • +13 more
Oct 21, 2020

Stage IV Fallopian Tube Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Primary Peritoneal Cancer AJCC

Completed
  • Stage IV Fallopian Tube Cancer AJCC v6 and v7
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Jul 1, 2020